Coya Therapeutics (COYA) News Today $6.10 +0.23 (+3.92%) Closing price 10/3/2025 03:59 PM EasternExtended Trading$6.31 +0.21 (+3.44%) As of 08:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COYA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Coya Therapeutics, Inc. (NASDAQ:COYA) Receives $16.20 Average Price Target from AnalystsOctober 5 at 2:47 AM | americanbankingnews.comBTIG Reiterates Coya Therapeutics (COYA) Buy RecommendationOctober 1, 2025 | msn.comCORE Public Relations Wins Platinum Pinnacle Awards for Healthcare and Technology PR CampaignsSeptember 30, 2025 | markets.businessinsider.comCoya Therapeutics, Inc. (NASDAQ:COYA) Receives Consensus Recommendation of "Buy" from AnalystsSeptember 30, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Receives Buy Rating from BTIG ResearchSeptember 30, 2025 | marketbeat.comCoya completes FTD combination therapy trial enrolmentSeptember 30, 2025 | finance.yahoo.comPositive Outlook for Coya Therapeutics Driven by Promising COYA-302 Clinical Developments and Regulatory SupportSeptember 30, 2025 | tipranks.comD. Boral Capital Maintains Coya Therapeutics (COYA) Buy RecommendationSeptember 30, 2025 | msn.comCoya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Patients ...September 29, 2025 | finance.yahoo.comCoya Therapeutics' (COYA) Buy Rating Reaffirmed at D. Boral CapitalSeptember 29, 2025 | marketbeat.comCoya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Patients with Mild to Moderate Frontotemporal DementiaSeptember 29, 2025 | prnewswire.comCoya Therapeutics (NASDAQ:COYA) Trading Up 3.4% - Should You Buy?September 27, 2025 | marketbeat.comLucid Capital Reaffirms Their Buy Rating on Coya Therapeutics, Inc. (COYA)September 25, 2025 | theglobeandmail.comPromising Outlook for COYA 302 Amidst Phase 2 Trial and Near-Term Catalysts Justifies Buy RatingSeptember 23, 2025 | tipranks.comCoya Therapeutics launches ALSTARS Trial to study efficacy of COYA 302September 23, 2025 | msn.comCoya Therapeutics Launches the ALSTARS Trial, a Phase 2 Clinical Study to Assess the Efficacy and Safety of COYA 302 in Amyotrophic Lateral SclerosisSeptember 22, 2025 | prnewswire.comChardan Capital Reiterates "Buy" Rating for Coya Therapeutics (NASDAQ:COYA)September 18, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Given "Buy" Rating at D. Boral CapitalSeptember 18, 2025 | marketbeat.comCoya Therapeutics' COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical ...September 17, 2025 | finance.yahoo.comCoya Therapeutics’ COYA 303 shows anti-inflammatory effect in animal studySeptember 16, 2025 | msn.comEXCLUSIVE: Coya Therapeutics Investigational Combination Therapy With GLP-1 Shows Potential For Alzheimer's DiseaseSeptember 16, 2025 | finance.yahoo.comCoya Therapeutics' COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation ModelSeptember 16, 2025 | prnewswire.comD. Boral Capital Reiterates Buy Rating for Coya Therapeutics (NASDAQ:COYA)September 6, 2025 | marketbeat.comCoya Therapeutics' COYA 302 ALS Trial Accepted by NEALS as a NEALS-Affiliated TrialSeptember 4, 2025 | prnewswire.comPRISM MarketView Features Exclusive Q&A with Coya Therapeutics CEO Arun Swaminathan on Targeting Neurodegenerative Diseases Through Treg TherapiesSeptember 3, 2025 | globenewswire.comCoya Therapeutics to Participate at Upcoming September Investor ConferencesSeptember 3, 2025 | prnewswire.comHC Wainwright Issues Optimistic Forecast for COYA EarningsAugust 29, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from D. Boral CapitalAugust 27, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Receives Buy Rating from HC WainwrightAugust 27, 2025 | marketbeat.comCoya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)August 27, 2025 | finance.yahoo.comFDA approves Coya Therapeutics’ trial of COYA 302 for ALSAugust 26, 2025 | msn.comCoya Therapeutics stock soars after FDA accepts IND for ALS treatmentAugust 25, 2025 | za.investing.comChardan Capital Has Bullish Outlook for COYA FY2025 EarningsAugust 19, 2025 | marketbeat.comCoya Therapeutics (NASDAQ:COYA) Earns "Buy" Rating from D. Boral CapitalAugust 15, 2025 | marketbeat.comChardan Capital Reaffirms Buy Rating for Coya Therapeutics (NASDAQ:COYA)August 15, 2025 | marketbeat.comCoya Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues LagAugust 14, 2025 | finance.yahoo.comCoya Therapeutics (NASDAQ:COYA) Issues Earnings ResultsAugust 13, 2025 | marketbeat.comCoya Therapeutics Reports Increased Losses Amid Development FocusAugust 12, 2025 | tipranks.comCoya Therapeutics, Inc.: Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate UpdateAugust 12, 2025 | finanznachrichten.deCoya Therapeutics files $75M mixed securities shelfAugust 12, 2025 | msn.comCoya Therapeutics Highlights Q2 2025 Financial ResultsAugust 12, 2025 | tipranks.comCoya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate UpdateAugust 12, 2025 | prnewswire.comCM Management LLC Raises Stock Position in Coya Therapeutics, Inc. (NASDAQ:COYA)August 7, 2025 | marketbeat.comCoya Therapeutics (COYA) Expected to Announce Quarterly Earnings on MondayAugust 5, 2025 | marketbeat.comDauntless Investment Group LLC Acquires Shares of 167,378 Coya Therapeutics, Inc. (NASDAQ:COYA)July 29, 2025 | marketbeat.comCoya Therapeutics' (COYA) "Buy" Rating Reiterated at D. Boral CapitalJuly 25, 2025 | marketbeat.comCoya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025July 22, 2025 | finance.yahoo.comCoya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025July 22, 2025 | businesswire.comLake Street Initiates Coverage of Coya Therapeutics (COYA) with Buy RecommendationJuly 10, 2025 | msn.comLake Street Capital Initiates Coverage on Coya Therapeutics (NASDAQ:COYA)July 9, 2025 | marketbeat.com Get Coya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COYA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COYA Media Mentions By Week COYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COYA News Sentiment▼0.360.54▲Average Medical News Sentiment COYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COYA Articles This Week▼123▲COYA Articles Average Week Get the Latest News and Ratings for COYA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Coya Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Benitec Biopharma News Today Tvardi Therapeutics News Today Lexeo Therapeutics News Today DiaMedica Therapeutics News Today Rocket Pharmaceuticals News Today Cullinan Therapeutics News Today Canopy Growth News Today enGene News Today Upexi News Today Amarin News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COYA) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
